Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Options Exercise | $380K | +13.9K | +89.53% | $27.34 | 29.4K | Feb 23, 2022 | Direct | F1 |
transaction | PFE | Common Stock | Tax liability | -$127K | -2.72K | -9.24% | $46.87 | 26.7K | Feb 23, 2022 | Direct | F2 |
transaction | PFE | Common Stock | Tax liability | -$352K | -6.87K | -25.76% | $51.28 | 19.8K | Feb 23, 2022 | Direct | F3, F4 |
holding | PFE | Common Stock | 9.69K | Feb 23, 2022 | By Rule 16b-3 Plan |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -13.9K | -100% | $0.00* | 0 | Feb 23, 2022 | Common Stock | 13.9K | $27.34 | Direct | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +42.3K | $0.00 | 42.3K | Feb 24, 2022 | Common Stock | 42.3K | $45.96 | Direct | F5 | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +37.2K | $0.00 | 37.2K | Feb 24, 2022 | Common Stock | 37.2K | $45.96 | Direct | F6 |
Id | Content |
---|---|
F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
F3 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
F4 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
F5 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
F6 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |